NCT04278547
Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response No drug interventions prevention 4 unknown_status NCT02136797
Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 completed NCT04832607
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections No drug interventions treatment 3 recruiting NCT00168259
Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals No drug interventions Not Available Not Available completed NCT05656599
Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies Not Available Not Available enrolling_by_invitation NCT01945619
Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) No drug interventions Not Available Not Available no_longer_available NCT06341686
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection treatment 3 not_yet_recruiting NCT02550639
Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant No drug interventions prevention 4 completed NCT02083731
MSC for Treatment of CMV Infection No drug interventions treatment 2 unknown_status NCT01633476
CMV Modulation of the Immune System in ANCA-associated Vasculitis basic_science 2 unknown_status NCT02843880
Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study No drug interventions Not Available Not Available terminated NCT02324244
CMV Intensive Care Units No drug interventions Not Available Not Available completed NCT06021210
Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS No drug interventions treatment 2 recruiting NCT05089838
CMV-TCR-T Cells for Refractory CMV Infection After HSCT No drug interventions treatment 1 unknown_status NCT03159364
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections No drug interventions treatment 1 / 2 unknown_status NCT05789615
Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China No drug interventions Not Available Not Available recruiting NCT02985775
Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation No drug interventions prevention 1 / 2 completed NCT06263218
Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil No drug interventions Not Available Not Available enrolling_by_invitation NCT02988258
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT No drug interventions treatment 1 suspended NCT02779439
Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation No drug interventions treatment 1 unknown_status NCT05315882
Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA No drug interventions Not Available Not Available completed NCT04934527
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection No drug interventions treatment 2 recruiting NCT06075927
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT No drug interventions treatment 1 / 2 not_yet_recruiting NCT04017962
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection No drug interventions treatment 2 active_not_recruiting NCT03798301
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells No drug interventions treatment 1 recruiting NCT03067155
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. No drug interventions treatment 2 completed NCT03210090
Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients No drug interventions Not Available Not Available unknown_status NCT02156479
Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients No drug interventions Not Available Not Available completed NCT04129398
MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042) prevention 3 completed NCT00942305
Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients prevention 2 completed NCT01178905
Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants No drug interventions prevention Not Available completed NCT03930615
Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040) prevention 3 completed NCT02454699
Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers treatment 1 completed NCT00370006
Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM No drug interventions prevention 1 completed NCT01473849
Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients No drug interventions Not Available Not Available unknown_status NCT00023036
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts No drug interventions Not Available Not Available completed NCT02328963
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A treatment 4 completed NCT00374686
Study of Prophylactic Vs Preemptive Valganciclovir prevention Not Available completed NCT00223925
Maribavir for Prevention of CMV After Stem Cell Transplants prevention 2 completed NCT05683457
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. No drug interventions prevention 2 recruiting NCT02103426
An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients No drug interventions prevention 1 completed NCT01199562
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Not Available Not Available completed NCT00880789
Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus No drug interventions treatment 1 completed NCT01354301
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate No drug interventions treatment 4 completed NCT00699868
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients No drug interventions Not Available Not Available completed NCT00373412
Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge No drug interventions prevention 1 completed NCT00386412
TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant No drug interventions treatment 2 completed NCT00194155
Cytomegalovirus (CMV) Infection in Pregnancy No drug interventions Not Available Not Available completed NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection No drug interventions treatment 2 recruiting NCT00817908
Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients No drug interventions Not Available Not Available completed NCT00273143
A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients. No drug interventions Not Available Not Available completed NCT03382405
Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults No drug interventions prevention 1 completed NCT06334497
Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections No drug interventions treatment 3 not_yet_recruiting NCT04975893
A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine No drug interventions prevention 2 enrolling_by_invitation NCT03910478
Dried Blood Spot Testing of CMV Detection in HCT Recipients No drug interventions diagnostic Not Available active_not_recruiting NCT01941056
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus No drug interventions supportive_care 1 completed NCT01588015
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 1 completed NCT00966836
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy No drug interventions prevention 3 unknown_status NCT00881517
Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection No drug interventions prevention 2 / 3 completed NCT00466817
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections No drug interventions treatment 3 completed NCT00400322
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection No drug interventions treatment Not Available completed NCT05105048
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 No drug interventions prevention 1 completed NCT05085366
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No drug interventions prevention 3 active_not_recruiting NCT00373165
Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients No drug interventions prevention 4 completed NCT02702427
Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation No drug interventions treatment 1 / 2 withdrawn NCT00001976
Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection No drug interventions Not Available Not Available completed NCT04232280
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults No drug interventions prevention 2 completed NCT02798692
Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV No drug interventions prevention 1 completed NCT01649869
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss No drug interventions treatment 2 completed NCT01552369
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") No drug interventions treatment 4 completed NCT00730769
Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients No drug interventions treatment 4 completed NCT01037712
In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir No drug interventions treatment 4 terminated NCT06133010
A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients No drug interventions prevention 2 withdrawn NCT01220895
Alternate Donor Study of Pre-Emptive Cellular Therapy No drug interventions prevention 2 completed NCT05763823
A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of CMV Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045) No drug interventions prevention 3 completed NCT01077908
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study No drug interventions prevention 3 completed NCT01651585
In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir treatment 4 completed NCT03629080
A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients No drug interventions prevention 2 completed NCT03940586
Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030) No drug interventions prevention 2 completed NCT00439803
A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) No drug interventions prevention 1 completed NCT03806764
Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient No drug interventions diagnostic Not Available enrolling_by_invitation NCT00031421
Neonatal CMV-Ganciclovir Follow-up Study No drug interventions Not Available Not Available completed NCT00228202
Genotyping of Cytomegalovirus From Patients in Israel No drug interventions Not Available Not Available unknown_status NCT02134184
The Influence of Chronic CMV Infection on Influenza Vaccine Responses No drug interventions basic_science 4 completed NCT01081379
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection No drug interventions Not Available Not Available unknown_status NCT04690933
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients No drug interventions Not Available Not Available recruiting NCT03699254
Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. prevention 3 completed NCT00431353
VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients treatment 4 completed NCT01353053
Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection No drug interventions Not Available Not Available unknown_status NCT00353977
Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors No drug interventions prevention 2 completed NCT02826798
Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults No drug interventions treatment 1 completed NCT00000805
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease No drug interventions treatment 1 completed NCT00133497
gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females No drug interventions prevention 2 completed NCT01070797
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) No drug interventions treatment 1 completed NCT03916497
Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients No drug interventions Not Available Not Available completed NCT03004261
CMV-CTL for the Treatment of CMV Infection After HSCT treatment 4 completed NCT05701228
Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation No drug interventions Not Available Not Available recruiting NCT04936971
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response prevention 4 withdrawn NCT02076971
Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive No drug interventions Not Available Not Available completed NCT04364178
Viral Specific T-Lymphocytes to Treat Adenovirus or CMV No drug interventions treatment 1 / 2 active_not_recruiting NCT06145178
A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants No drug interventions prevention 1 recruiting NCT00004278
Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection No drug interventions treatment 3 completed NCT03858907
Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV No drug interventions Not Available Not Available unknown_status NCT01034709
Evaluation of the Artus® CMV PCR Test No drug interventions Not Available Not Available completed NCT02007356
A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® No drug interventions treatment 2 recruiting NCT01535885
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV No drug interventions prevention 1 completed NCT01594437
Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody treatment 1 completed NCT00002352
A Study of Lobucavir in Patients With AIDS No drug interventions treatment Not Available completed NCT02715752
A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin No drug interventions Not Available Not Available completed NCT00194142
Cytomegalovirus (CMV) Infection in Amniotic Fluid No drug interventions Not Available Not Available completed NCT01325636
Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus No drug interventions treatment 1 / 2 completed NCT02671318
Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence prevention 4 unknown_status NCT00377741
A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. treatment 1 completed NCT02346617
Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection No drug interventions treatment 1 / 2 withdrawn NCT00031434
Valganciclovir in Congenital CMV Infants No drug interventions treatment 1 / 2 completed NCT00002024
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections No drug interventions treatment Not Available completed NCT04439916
Breakthrough CMV Lung Transplant -Multicentre No drug interventions Not Available Not Available recruiting NCT00005496
Inflammation, Infection, and Future Cardiovascular Risk No drug interventions Not Available Not Available completed NCT06058858
Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis No drug interventions Not Available Not Available recruiting NCT00002025
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient No drug interventions treatment Not Available completed NCT02840825
Biochip for HCMV Detection in Breast Milk No drug interventions Not Available Not Available terminated NCT05626530
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients prevention 4 recruiting NCT00674648
Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants No drug interventions treatment 1 completed NCT00201448
Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women prevention 2 / 3 terminated NCT02943057
Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis treatment 4 active_not_recruiting NCT03915366
Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia treatment 2 / 3 active_not_recruiting NCT00090766
A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients treatment 2 / 3 completed NCT02600065
Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy No drug interventions Not Available Not Available completed NCT05099965
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) treatment 2 active_not_recruiting NCT00001082
The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients No drug interventions treatment 3 completed NCT00004573
Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR No drug interventions diagnostic Not Available unknown_status NCT04030676
QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis No drug interventions diagnostic Not Available recruiting NCT05370976
Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. No drug interventions treatment 2 recruiting NCT03262194
Relevance of Gastric Aspirate in HCMV Detection No drug interventions Not Available Not Available terminated NCT02062294
An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients No drug interventions Not Available Not Available completed NCT02683291
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients treatment 4 completed NCT06572462
ATG Individualized Dosing Model in URD-PBSCT. No drug interventions treatment 2 recruiting NCT06522880
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study No drug interventions Not Available Not Available recruiting NCT00372229
A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation prevention 3 completed NCT00001089
A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients No drug interventions Not Available Not Available completed NCT01251744
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus No drug interventions other Not Available completed NCT05305040
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant No drug interventions prevention 2 / 3 terminated NCT05532540
Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study No drug interventions Not Available Not Available recruiting NCT01753167
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients No drug interventions treatment 2 completed NCT02538172
Cell-mediated Immunity for Prevention of CMV Disease No drug interventions prevention Not Available completed NCT00566072
The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial No drug interventions supportive_care Not Available completed NCT02439372
Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis No drug interventions Not Available Not Available completed NCT00002268
A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria No drug interventions treatment 1 completed NCT00002146
Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study No drug interventions treatment 4 completed NCT03475212
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 active_not_recruiting NCT00000881
A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease No drug interventions treatment 1 withdrawn NCT00002095
A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus No drug interventions treatment Not Available completed NCT00000995
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection No drug interventions treatment Not Available completed NCT01602614
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection No drug interventions Not Available Not Available completed NCT04904614
Letermovir Use in Heart Transplant Recipients No drug interventions other 4 active_not_recruiting NCT06337955
Non Primary HCMV Infection: Natural History and Immune Response No drug interventions Not Available Not Available active_not_recruiting NCT03146208
Role of Endothelial Biomarkers in Patients With Coronary Artery Disease No drug interventions Not Available Not Available unknown_status NCT06341543
Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) No drug interventions other Not Available not_yet_recruiting NCT00264290
Valganciclovir to Reduce T Cell Activation in HIV Infection No drug interventions treatment 4 completed NCT05183490
R-MVST Cells for Treatment of Viral Infections No drug interventions treatment 1 recruiting NCT00001890
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections No drug interventions treatment 2 completed NCT00125502
Recombinant CMV gB Vaccine in Postpartum Women No drug interventions prevention 2 completed NCT02982902
T Cell Therapy of Opportunistic Cytomegalovirus Infection No drug interventions supportive_care 0 recruiting NCT00000584
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates No drug interventions prevention 3 completed NCT06027879
Anti-viral T-cell Therapy by Gamma Capture No drug interventions treatment 1 / 2 enrolling_by_invitation NCT03188679
Development of Potential Biomarkers for Foetal Brain Development After Congenital CMV Infection No drug interventions basic_science Not Available unknown_status NCT00284687
Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients No drug interventions treatment 3 completed NCT00078533
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant No drug interventions treatment 1 completed NCT00002251
A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir No drug interventions treatment Not Available completed NCT00237653
MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus No drug interventions treatment 3 terminated NCT05091177
Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis No drug interventions Not Available Not Available unknown_status NCT01274377
Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT No drug interventions prevention 1 terminated NCT00005547
Infection and Cardiovascular Disease No drug interventions Not Available Not Available completed NCT00241345
Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant No drug interventions treatment 3 terminated NCT00006145
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV No drug interventions prevention 3 completed NCT00411645
Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients No drug interventions prevention 3 completed NCT06554197
Evaluation of CMV/EBV-CMI in Haploid HSCT No drug interventions Not Available Not Available recruiting NCT00000593
Viral Activation Transfusion Study (VATS) No drug interventions prevention Not Available completed NCT01927588
Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients No drug interventions treatment 4 unknown_status NCT00005309
Prospective Study of HIV Infection in Hemophiliacs No drug interventions Not Available Not Available completed NCT00294515
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients No drug interventions treatment 3 completed NCT00034437
Immune Response to Cytomegalovirus No drug interventions Not Available Not Available completed NCT04693637
Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant No drug interventions prevention 2 / 3 completed NCT06407232
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients No drug interventions treatment 3 recruiting NCT00001100
A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections. No drug interventions treatment 3 completed NCT00227370
Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation No drug interventions prevention 3 completed NCT00170170
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation No drug interventions Not Available Not Available completed NCT00004642
Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease No drug interventions treatment 1 / 2 completed NCT00029406
Transfusion Infections Pediatric Prospective Study (TRIPPS) No drug interventions Not Available Not Available completed NCT01819519
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus No drug interventions prevention Not Available completed NCT02684734
Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis No drug interventions Not Available Not Available completed NCT03631316
Pharmacokinetic Parameters of Innovative Valganciclovir Versus Generic Valganciclovir No drug interventions prevention Not Available completed NCT02683096
Screening for Congenital Cytomegalovirus Infection in Newborns No drug interventions Not Available Not Available completed NCT00497796
Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients No drug interventions prevention 3 completed NCT00002096
A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine No drug interventions treatment 1 completed NCT01972035
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation No drug interventions prevention 2 completed NCT03698435
(Val)Ganciclovir TDM in Transplant Recipients No drug interventions Not Available Not Available unknown_status NCT02642822
The Epidemiologic Study of Human Cytomegalovirus（CMV） in Female Students of Xiamen University No drug interventions Not Available Not Available completed NCT05089630
A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults No drug interventions prevention 1 / 2 active_not_recruiting NCT06066957
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients No drug interventions treatment 2 recruiting NCT03728426
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection No drug interventions treatment 2 completed NCT02129465
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy No drug interventions Not Available Not Available unknown_status NCT00815165
Cytomegalovirus Cell-Mediated Immunity No drug interventions Not Available Not Available completed NCT04478474
Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients No drug interventions Not Available Not Available completed NCT03840174
Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003) No drug interventions prevention 1 completed NCT00005274
Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) No drug interventions Not Available Not Available completed NCT00001531
Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction No drug interventions Not Available Not Available completed NCT00002373
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients No drug interventions treatment 1 completed NCT00299260
CMV Glycoprotein B Vaccine in Allograft Recipients No drug interventions prevention 2 unknown_status NCT04225780
Treatment of Low Dose IL-2 and Ganciclovir in Cytomegalovirus Infection No drug interventions treatment 1 / 2 unknown_status NCT00302029
CMV Infection in Adolescent Males No drug interventions Not Available Not Available terminated NCT06339892
HCMV Breakthrough Infections During Letermovir Prophylaxis No drug interventions diagnostic Not Available recruiting NCT03266640
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) No drug interventions treatment 2 recruiting NCT01663740
A Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valganciclovir (Valcyte®) Versus Untreated Matched Controls No drug interventions other 4 completed NCT04906304
Comparison of Safety and Efficacy of de Novo Everolimus No drug interventions treatment Not Available completed NCT00005572
A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection No drug interventions Not Available Not Available completed NCT00673868
Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants No drug interventions treatment 1 completed NCT00264368
Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy No drug interventions treatment 4 terminated NCT04067869
Cytomegalovirus Infection in Patients With HIV-1 Infection No drug interventions treatment 3 completed NCT02084446
Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant No drug interventions prevention 4 completed NCT04658810
Assessment of Post-traumatic Stress Disorder (PTSD) in Patients Monitored for Cytomegalovirus (CMV) Seroconversion During Pregnancy, No drug interventions Not Available Not Available completed NCT01986010
Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001) No drug interventions prevention 1 completed NCT00000981
The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS No drug interventions treatment 2 completed NCT03950414
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients No drug interventions treatment 1 terminated NCT00006314
Cytomegalovirus Spread and Reactivation in Blood Cells No drug interventions Not Available Not Available completed NCT03576014
Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient No drug interventions prevention 1 unknown_status NCT05234723
Ganciclovir Resistant Cytomegalovirus Infection in SOT Recipients. No drug interventions Not Available Not Available unknown_status NCT00001038
A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients No drug interventions treatment 3 completed NCT04183738
Inflammation and Co-Infections in D²EFT No drug interventions basic_science 4 withdrawn NCT03576898
Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis No drug interventions treatment 2 / 3 not_yet_recruiting NCT02313857
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C) No drug interventions treatment 1 completed NCT01357915
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine No drug interventions prevention Not Available completed NCT01691820
A Study in Adolescent Females to Explore Cytomegalovirus Infection No drug interventions screening Not Available completed NCT06057194
Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. treatment 2 not_yet_recruiting NCT00435396
Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects No drug interventions prevention 1 completed NCT03486834
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002) No drug interventions prevention 2 completed